The drug delivery landscape is evolving rapidly, with micro moulding driving evolving trends in self-injection devices and increasing drive towards sustainability. At the same time, sweeping regulatory shifts are reshaping the future of combination product development, as U.S. policy accelerates domestic drug approvals and heightens oversight of global manufacturing practices.

Built for device innovators by industry pioneers, the 15th Injectable Device Development Summit will unite 70+ senior leaders from pharma, biotech, and device service providers including Eli Lilly, Takeda, Sanofi, and Merck, to unpack how to enable flexible, patient-centric delivery platforms for high-viscosity, large-volume formulations. From advancing platform strategies to de-risking regulatory pathways and improving real-world usability, this is your essential forum to drive forward next-generation delivery systems that meet the needs of both regulators and patients.

See the event details here.